Published in J Neurochem on March 14, 2011
Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem (2013) 1.02
HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS. Curr HIV Res (2012) 0.98
Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytes. PLoS One (2012) 0.85
HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling. Retrovirology (2013) 0.83
Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression. PLoS One (2013) 0.81
Involvement of estrogen receptor β5 in the progression of glioma. Brain Res (2013) 0.81
HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Front Microbiol (2015) 0.80
C/EBPβ regulates multiple IL-1β-induced human astrocyte inflammatory genes. J Neuroinflammation (2012) 0.79
Metalloproteinase-dependent TLR2 ectodomain shedding is involved in soluble toll-like receptor 2 (sTLR2) production. PLoS One (2014) 0.78
Activation of the inflammatory transcription factor nuclear factor interleukin-6 during inflammatory and psychological stress in the brain. J Neuroinflammation (2013) 0.76
Inflammation-induced miRNA-155 inhibits self-renewal of neural stem cells via suppression of CCAAT/enhancer binding protein β (C/EBPβ) expression. Sci Rep (2017) 0.75
Cytosolic phospholipase A2 regulates alcohol-mediated astrocyte inflammatory responses in HIV-associated neurocognitive disorders. Cell Death Discov (2015) 0.75
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J (1990) 9.17
Astrocytes: biology and pathology. Acta Neuropathol (2009) 8.43
Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci (2004) 5.70
Uniquely hominid features of adult human astrocytes. J Neurosci (2009) 3.49
Reactive astrocytes in neural repair and protection. Neuroscientist (2005) 3.47
STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci (2008) 3.44
Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med (2005) 2.51
C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell (1994) 2.42
Matrix metalloproteinases and diseases of the CNS. Trends Neurosci (1998) 2.24
HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol (2010) 1.87
An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron (2002) 1.79
CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol (2009) 1.73
Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol (1998) 1.60
Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol (2009) 1.59
Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals (2008) 1.46
Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia (2000) 1.42
P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci (2001) 1.38
Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med (1996) 1.34
Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120. Neurobiol Aging (2006) 1.33
Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol (2004) 1.31
CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. J Neurochem (1998) 1.29
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J Neurosci (1997) 1.27
Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia (2003) 1.22
Microarray analysis supports a role for ccaat/enhancer-binding protein-beta in brain injury. J Biol Chem (2004) 1.21
A transcriptional role for C/EBP beta in the neuronal response to axonal injury. Mol Cell Neurosci (2005) 1.21
Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol Biol (Paris) (2003) 1.15
Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood (2008) 1.15
Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res (2003) 1.15
Transcriptional regulation of scar gene expression in primary astrocytes. Glia (2007) 1.15
Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am J Pathol (2006) 1.14
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease. Exp Neurol (2002) 1.13
Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol Dis (2006) 1.13
Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur J Neurosci (2005) 1.10
Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat. Mol Cell Biol (1994) 1.10
Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist. J Immunol (1996) 1.09
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J Neurol Sci (2003) 1.05
Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Glia (2007) 1.04
Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases. J Neurosci Res (2006) 1.04
Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis (2000) 1.03
Expressions of CCAAT/Enhancer-binding proteins beta and delta and their activities are intensified by cAMP signaling as well as Ca2+/calmodulin kinases activation in hippocampal neurons. J Biol Chem (1998) 1.01
A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons. PLoS One (2009) 1.01
Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol (2009) 0.97
Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett (1999) 0.97
Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice. Behav Brain Res (2006) 0.95
Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J (1997) 0.95
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. Int Psychogeriatr (2007) 0.94
Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochem Res (2004) 0.93
Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation. J Neurosci Res (2006) 0.92
Age-dependent response of CCAAT/enhancer binding proteins following traumatic brain injury in mice. Neurochem Int (2009) 0.92
Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury. Glia (2000) 0.91
The human tissue inhibitor of metalloproteinases (TIMP)-1 gene contains repressive elements within the promoter and intron 1. J Biol Chem (2000) 0.83
A sequence-selective single-strand DNA-binding protein regulates basal transcription of the murine tissue inhibitor of metalloproteinases-1 (Timp-1) gene. J Biol Chem (1999) 0.80
Adenocarcinoma in a continent colonic urinary reservoir. Urology (1998) 0.77
Transcriptional regulation of the human tissue inhibitor of metalloproteinases-1: mapping transcriptional control in intron-1. Ann N Y Acad Sci (1999) 0.76
The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett (2006) 2.79
Matrix metalloproteinases in arthritic disease. Arthritis Res (2002) 1.75
A functional transsulfuration pathway in the brain links to glutathione homeostasis. J Biol Chem (2006) 1.61
HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta. Glia (2006) 1.40
Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology (2003) 1.39
Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcohol Clin Exp Res (2005) 1.37
Interleukin-11, IL-11 receptoralpha and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window. J Reprod Immunol (2005) 1.29
Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia (2003) 1.22
Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob Agents Chemother (2007) 1.18
Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res (2003) 1.15
Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis. Am J Pathol (2006) 1.15
Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics. Leuk Res (2008) 1.15
Gastric mixed adenoneuroendocrine carcinoma with a trilineage cell differentiation: case report and review of the literature. Case Rep Oncol (2012) 1.10
Primary epithelial lung malignancies in the pediatric population. Pediatr Blood Cancer (2005) 1.08
Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv (2009) 1.05
Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases. J Neurosci Res (2006) 1.04
Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem (2013) 1.02
Metagenomic comparison of direct and indirect soil DNA extraction approaches. J Microbiol Methods (2011) 1.02
Alcohol and HIV decrease proteasome and immunoproteasome function in macrophages: implications for impaired immune function during disease. Cell Immunol (2004) 1.02
Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J Neuroimmunol (2003) 1.01
Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity. J Neurochem (2003) 0.98
HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS. Curr HIV Res (2012) 0.98
Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J Neurosci Res (2003) 0.98
Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl Biochem Biotechnol (2008) 0.95
Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation. J Neurosci Res (2006) 0.92
Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis. J Neurovirol (2004) 0.92
Cytopathologic analysis of thyroid lesions in the pediatric population. Diagn Cytopathol (2006) 0.90
HIV-1 and IL-1β regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-κB signaling mechanisms. J Neuroinflammation (2011) 0.87
Development of a rapid autopsy program for studies of brain immunity. J Neuroimmunol (2005) 0.87
CD38 regulation in activated astrocytes: implications for neuroinflammation and HIV-1 brain infection. J Neurosci Res (2009) 0.86
Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytes. PLoS One (2012) 0.85
Ultrafast infrared spectroscopy of an isotope-labeled photoactivatable flavoprotein. Biochemistry (2011) 0.85
Astrocyte elevated gene-1 regulates astrocyte responses to neural injury: implications for reactive astrogliosis and neurodegeneration. J Neuroinflammation (2012) 0.84
Modulation of polymorphonuclear neutrophil functions by astrocytes. J Neuroinflammation (2010) 0.84
Isolation and HIV-1 infection of primary human microglia from fetal and adult tissue. Methods Mol Biol (2005) 0.84
Vibrational assignment of the ultrafast infrared spectrum of the photoactivatable flavoprotein AppA. J Phys Chem B (2012) 0.83
Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration. Biochem Biophys Res Commun (2010) 0.82
Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects. J Neuroimmunol (2005) 0.82
The unfolded protein response is activated in Helicobacter-induced gastric carcinogenesis in a non-cell autonomous manner. Lab Invest (2012) 0.81
Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression. PLoS One (2013) 0.81
Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons. AIDS Res Hum Retroviruses (2011) 0.80
CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia. J Neuroimmune Pharmacol (2008) 0.80
CXCL8 protects human neurons from amyloid-β-induced neurotoxicity: relevance to Alzheimer's disease. Biochem Biophys Res Commun (2011) 0.79
C/EBPβ regulates multiple IL-1β-induced human astrocyte inflammatory genes. J Neuroinflammation (2012) 0.79
Building bridges of understanding through continuing education and professional development of Arabs and Israelis. J Contin Educ Health Prof (2005) 0.78
Antitoxin approach to malaria. Lancet (2002) 0.76
Healthcare Assistants: distributional losses as a consequence of NHS modernisation? New Technol Work Employ (2015) 0.75
PfHRP2 measures schizogony, not mechanical blockage. PLoS Med (2006) 0.75
Degradation pathways of dissolved carbon in landfill leachate traced with compound-specific (13)C analysis of DOC. Isotopes Environ Health Stud (2008) 0.75
The Hammersmith Hospital hematopathology case of the month: paraspinal B lymphoblastic lymphoma – problems in diagnosis and initial indolent behavior. Leuk Lymphoma (2010) 0.75
Bioattenuation in groundwater impacted by landfill leachate traced with δ13C. Ground Water (2011) 0.75